Sorrento Therapeutics Inc

SRNE

$7.94

+25.1% (1 year change)

Market Cap

$2.39 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$5.17 - $17.25

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$0.00 (0.0%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $2.39 Billion
Enterprise Value -
Dividend Yield $0.00 (0.0%)
1 Year Return +25.1%
52-Week High $17.25
52-Week Low $5.17
Beta 0.56
Outstanding Shares 298 Million
Avg 30 Day Volume 4.91 Million

Valuation

P/E Ratio 0.0
PEG -
Earnings per Share $0.00
Price to Sales Ratio -
Price to Book Ratio -
Revenue to Enterprise Value -
EBIT to Enterprise Value -
Total Debt to Enterprise Value -
Debt to Equity -

Profitability

Revenue -
Gross Profit -
EBIT -
Net Income -
Profit Margin -
Quarterly Earnings Growth (YoY) -
Return on Equity -
Return on Assets -
Return on Invested Capital -

News

Dr. Henry Ji, Sorrento Chairman and CEO, to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021

Dr. Henry Ji, Sorrento Chairman and CEO, to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021

SAN DIEGO, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that Dr. Henry Ji, Chairman and CEO, will participate in the H.C. Wainwright 23...

Intrado Digital Media Intrado Digital Media, 5 days ago
Sorrento Therapeutics Inc (SRNE): Price Down $-0.01 (-0.19)% Over Past Day, Down $-0.02 (-0.27)% Over Past Hour

Sorrento Therapeutics Inc (SRNE): Price Down $-0.01 (-0.19)% Over Past Day, Down $-0.02 (-0.27)% Over Past Hour

Regarding the trend, note that the strongest trend exists on the 20 day timeframe. The post Sorrento Therapeutics Inc (SRNE): Price Down $-0.01 (-0.19)% Over Past Day, Down $-0.02 (-0.27)% Over Pas...

ETF Daily News ETF Daily News, 8 days ago
Adoptive T cell therapy Market Giants Spending Is Going To Boom |Top key players-Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG

Adoptive T cell therapy Market Giants Spending Is Going To Boom |Top key players-Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG

Adoptive T cell Therapy, otherwise called cell immunotherapy, is a type of therapy that utilizes the phones of our resistant framework to wipe out malignant growth. A portion of these methodologies...

OpenPR OpenPR, 10 days ago